A 3 years PhD position is available at Covalab-France to work on the development of novel specific inhibitors to tissue transglutaminase and related tests in the framework of TRANSPATH (Transglutiminase in disease: a novel therapeutic target) a FP7 Marie Curie Initial Training Networks (ITN) project.

For more information: http://ec.europa.eu/euraxess/index.cfm/jobs/jobDetails/33760145